Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cetylpyridinium chloride is a quaternary ammonium compound and cationic surfactant widely used as an antiseptic and disinfectant in over-the-counter oral care products such as mouthwashes, toothpastes, lozenges, throat sprays, breath sprays, and nasal sprays. It acts primarily by disrupting microbial cell membranes through its cationic surface-active properties. The positively charged hydrophilic region of the molecule interacts with bacterial cell surfaces and integrates into the cytoplasmic membrane via its hydrophobic tail. This leads to disruption of membrane integrity, leakage of cytoplasmic contents, interference with cellular metabolism and homeostasis (including osmoregulation), inhibition of cell growth, and ultimately cell death. Cetylpyridinium chloride demonstrates rapid bactericidal activity against gram-positive bacteria and fungicidal effects on yeasts but is less effective against gram-negative pathogens and mycobacteria. Its primary indications are for reducing dental plaque formation, gingivitis prevention/treatment, minor oral infections management (including oropharyngeal candidiasis), and as a preservative in pharmaceutical formulations[1][2][3][4][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cetylpyridinium chloride.